The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma

David A. Karnofsky; Walter H. Abelmann; Lloyd F. Craver; Joseph H. Burchenal

doi:10.1002/1097-0142(194811)1:4<634::aid-cncr2820010410>3.0.co;2-l

Keywords

MedicineBronchogenic carcinomaPalliative careCancerCarcinomaGerontologyInternal medicineNursing

Affiliated Institutions

Related Publications

Neu-Protein Overexpression in Breast Cancer

Marc J. van de Vijver , Johannes L. Peterse , Wolter J. Mooi +4 more

Amplification of the neu proto-oncogene in breast cancer has been reported to correlate with the presence of lymph-node metastases and with a poor prognosis. We describe a metho...

1988 New England Journal of Medicine 858 citations

Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic

A. J. Salsbury , Karen Burrage , K. Hellmann

Treatment with I.C.R.F. 159 completely inhibited metastasis formation in mice implanted with Lewis lung carcinoma at doses having little influence on the rate of growth of the p...

1970 BMJ 90 citations

Nasopharyngeal carcinoma

Yu‐Pei Chen , Anthony T.�C. Chan , Quynh‐Thu Le +3 more

Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is particularly prevalent in east and southeast Asia. Epidemiological trends in the past deca...

2019 The Lancet 2829 citations

Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps—From the American Society of Clinical Oncology

Frank D. Ferris , Éduardo Bruera , Nathan I. Cherny +7 more

Purpose In 1998, the American Society of Clinical Oncology (ASCO) published a special article regarding palliative care and companion recommendations. Herein we summarize the ma...

2009 Journal of Clinical Oncology 399 citations

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Publication Info

Year: 1948
Type: article
Volume: 1
Issue: 4
Pages: 634-656
Citations: 2215
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2215

OpenAlex

Cite This

APA Style

                            
                                
                                    David A. Karnofsky, 
                                
                                    Walter H. Abelmann, 
                                
                                    Lloyd F. Craver
                                
                                et al.
                            
                            (1948). 
                            The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma. 
                            Cancer
                            , 1
                            (4)
                            , 634-656.
                            https://doi.org/10.1002/1097-0142(194811)1:4<634::aid-cncr2820010410>3.0.co;2-l
                        

Identifiers

DOI: 10.1002/1097-0142(194811)1:4<634::aid-cncr2820010410>3.0.co;2-l